Thiobutabarbital
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5-sec-butyl-5-ethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | |
| Identifiers | |
| CAS Number |
2095-57-0 |
| ATC code | none |
| PubChem | CID 3032373 |
| ChemSpider |
2297366 |
| UNII |
2N0251U7JH |
| Synonyms | Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid |
| Chemical data | |
| Formula | C10H16N2O2S |
| Molar mass | 228.312 g/mol |
| |
| |
| | |
Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia [1]
References
- ↑ Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Oct;370(4):320-3.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
